Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth.

Autor: Pich C; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland., Meylan P; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland., Mastelic-Gavillet B; Department of Oncology, University of Lausanne, Ludwig Cancer Research Center, Lausanne, Switzerland., Nguyen TN; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland., Loyon R; Department of Oncology, University of Lausanne, Ludwig Cancer Research Center, Lausanne, Switzerland., Trang BK; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland., Moser H; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland., Moret C; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland., Goepfert C; COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland., Hafner J; Department of Dermatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland., Levesque MP; Department of Dermatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland., Romero P; Department of Oncology, University of Lausanne, Ludwig Cancer Research Center, Lausanne, Switzerland., Jandus C; Department of Oncology, University of Lausanne, Ludwig Cancer Research Center, Lausanne, Switzerland., Michalik L; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland. liliane.michalik@unil.ch.

Publikováno v: Cancer research [Cancer Res] 2018 Nov 15; Vol. 78 (22), pp. 6447-6461. Date of Electronic Publication: 2018 Sep 05.